Gene: NAA20
Official Full Name: N-alpha-acetyltransferase 20, NatB catalytic subunitprovided by HGNC
Gene Summary: NAT5 is a component of N-acetyltransferase complex B (NatB). Human NatB performs cotranslational N(alpha)-terminal acetylation of methionine residues when they are followed by asparagine (Starheim et al., 2008 [PubMed 18570629]).[supplied by OMIM, Apr 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00036 | NAA20 Knockout cell line (HeLa) | Human | NAA20 | 1:3~1:6 | Negative | Online Inquiry |
NAA20 Gene Knockout Cell Lines are a series of genetically engineered cellular models specifically designed to facilitate in-depth studies of the NAA20 gene's functions and its involvement in various biological pathways. By utilizing advanced CRISPR-Cas9 gene editing technology, these cell lines have been generated to enable the precise knockout of the NAA20 gene, allowing researchers to investigate the molecular mechanisms underlying gene regulation, protein acetylation, and their implications in cellular processes.
The key functions of NAA20 knockout cell lines center around the elucidation of NAA20's role in the N-terminal acetylation of proteins, a post-translational modification that is pivotal in regulating protein stability, localization, and interactions. Researchers can leverage these cell lines to assess the phenotypic changes resulting from the loss of NAA20 function, thereby providing critical insights into cellular signaling and the overall impact on health and disease.
The scientific importance of NAA20 knockout cell lines extends into both basic research and clinical applications. For example, understanding the gene’s contribution to diseases such as cancer and neurodegenerative disorders is invaluable for developing targeted therapies. Furthermore, these cell lines enable high-throughput screening for small molecules that may modulate NAA20 activity, thus broadening therapeutic horizons.
Compared to traditional models, NAA20 Gene Knockout Cell Lines offer several advantages, including specificity of gene targeting, reproducibility, and the capacity for functional assays without the confounding effects of off-target mutations. This leads to more reliable data and insights that can accelerate the research process.
For researchers and clinicians, the value of NAA20 Gene Knockout Cell Lines lies in their ability to provide a robust platform for the dissection of complex biological questions and the development of novel therapeutics. They represent an essential resource for those aiming to explore the nuances of protein modulation and its broader implications in health and disease.
Our company specializes in the development of innovative biological products grounded in cutting-edge research. We are dedicated to supporting the scientific community with high-quality tools that enhance the exploration of genetic functions and cellular mechanisms.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.